Journal
CLINICAL GENETICS
Volume 75, Issue 4, Pages 384-393Publisher
WILEY
DOI: 10.1111/j.1399-0004.2008.01141.x
Keywords
9q22; 3; genomic imprinting; Gorlin syndrome; microarray-based comparative genomic hybridization; overgrowth; PTCH1
Categories
Funding
- International Research and Educational Institute for Integrated Medical Sciences
- Program for Promoting the Establishment of Strategic Research Centers
- Ministry of Education, Culture, Sports, Science and Technology (Japan)
Ask authors/readers for more resources
Shimojima K, Adachi M, Tanaka M, Tanaka Y, Kurosawa K, Yamamoto T. Clinical features of microdeletion 9q22.3 (pat).Clin Genet 2009: 75: 384-393. (C) Blackwell Munksgaard, 2009 Congenital anomaly syndromes manifesting overgrowth are rare, and only a small number of recognized or defined conditions are known to be associated with overgrowth. Some of them are related to genomic imprinting as a genetic cause. We report a girl who showed pre- and postnatal overgrowth who was found to have a 2.3-Mb deletion of 9q22.32 involving PTCH1, the gene responsible for Gorlin syndrome (nevoid basal cell carcinoma syndrome), by array-comparative genomic hybridization analysis. Clinical re-evaluation according to the diagnostic criteria was performed after identification of the PTCH1 deletion, and the patient was then diagnosed as having Gorlin syndrome. Further delineation involved unusual features including cerebellar dysplasia, an ectopic meninx on her shoulder, and an intraorbital hemangioma. Overgrowth is not a common finding in Gorlin syndrome. We reviewed 23 patients reported to have a 9q22 deletion. Five patients, including our patient, had overgrowth and loss of the paternal allele.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available